<Job Description>

Cell Therapy Field Clinical Advisors (FCAs) are part of the Global Cell Therapy Clinical Operations team and play a critical role in the successful execution of cell therapy clinical trials—driving recruitment, retention and safety management while enabling early insight generation. FCAs focus on clinical study protocol expertise and education, optimizing the patient journey, and cell therapy pipeline engagement. The role requires close collaboration with other CTCO Functions, Clinical Development, and Medical Affairs across multiple indications and business units to advance AstraZeneca’s diverse cell therapy portfolio.


<Typical Accountabilities>

Scientific Expertise and Education
￣￣￣￣￣￣￣￣￣￣￣￣￣￣￣￣
・Pipeline Mastery at Scale: Build and continuously maintain deep knowledge of AstraZeneca’s cell therapy pipeline across multiple indications and assets.
・Recognized Thought Leadership: Establish and sustain highest-level scientific and medical expertise in cell therapy; recognized internally and externally as a go-to expert, shaping guidance, training, and best practices for assigned protocols and sites
・Strategic Portfolio Communication: Lead site-facing and expert stakeholder communications that clearly convey AstraZeneca’s cell therapy strategy, portfolio breadth, and product differentiation; ensure consistent, compliant messaging across regions.
・Initiative Ownership and Execution: Design, lead, and implement high-impact local initiatives with trialists and key experts to support R&D or study implementation, aligned with GPT, Global R&D, and Country Medical Affairs; track outcomes and scale successful approaches.
・Education Gap Identification and Closure: Systematically assess educational needs across owned sites, deliver advanced protocol training, and escalate patterns to Global Clinical Development with recommendations for enterprise-level solutions.
・Insight Generation and Influence: Capture, synthesize, and deliver actionable field insights (feasibility, operational bottlenecks, patient pathways) to global and local stakeholders; drive early risk identification and influence protocol/process adjustments.

Clinical Trial Support
￣￣￣￣￣￣￣￣￣￣
・Advanced Education and Readiness: Lead delivery of SIV content; provide advanced protocol education and competency-based staff training to ensure readiness, compliance, and consistency across sites and indications. Drive patient selection quality, safety management, and site-specific action plans; deliver measurable improvements in start-up timelines and protocol adherence
・Recruitment and Retention Performance: Implement targeted protocol education (e.g., inclusion/exclusion criteria application etc.) to uplift enrolment rates, reduce screen failures, and minimize attrition.
・Issue Triage, Escalation, and Risk Mitigation: Serve as the primary field point for protocol and clinical issues; triage and escalate appropriately, drive root-cause analysis, and implement corrective/preventive actions to reduce deviations and data queries.
・Structured, Compliant Scientific Exchange: Lead timely, high-quality scientific and medical communications with trialists and internal partners, ensuring alignment with compliance policies and legal requirements; standardize messaging and capture learnings for reuse.
・Insight Loop and Continuous Improvement: Systematically capture site-level insights; synthesize trends for study teams and cross-functional stakeholders, influencing protocol/process adjustments and scaling proven practices.

Operational
￣￣￣￣￣￣
・Cross-functional orchestration: Lead coordinated delivery with CTCO Functions, Clinical Development, Medical Affairs, Supply/Logistics, Patient Operations and Country Ops to ensure rapid, reliable service to internal stakeholders and study sites.
・Portfolio coverage and resiliency: Provide proactive coverage for other FCAs and high-priority sites; implement standardized playbooks to maintain continuity of operations during surges, vacations, or escalations.
・Regulatory and policy stewardship: Maintain current knowledge of local regulations, guidelines, codes of practice, and AstraZeneca policies relevant to Clinical Development; translate requirements into practical site actions and support inspection readiness.
・External scientific engagement: Attend and contribute at relevant scientific meetings and conferences; synthesize takeaways into concise briefs and recommendations for study teams and operational processes.
・Innovation sourcing and scaling: Build relationships with industry leaders and ecosystem partners; identify, pilot, and scale innovations (e.g., workflow tools, logistics optimizations, patient support solutions) that improve cycle times, quality, and site experience.

Cross Functional
￣￣￣￣￣￣￣￣
・Global workstreams: Provide country specific field insights and subject-matter expertise to priority global initiatives; review/shape core strategies and deliverables to enable scalable, locally compliant adoption.
・Medical Affairs: Partner on scientific strategy, congress/education plans, and field content; ensure accuracy, balance, and governance compliance across materials and training.
・Commercial (within governance): Coordinate through approved interfaces to align on market dynamics and objectives
・Evidence and insights: Elevate actionable field signals to inform global research strategy and lifecycle plans; ensure traceability from signal to decision.
・Governance: Operate within AZ policies/SOPs and local regulations

Impact
￣￣￣
・Operational velocity and quality: Directly improve speed, quality, and consistency of AstraZeneca’s cell therapy trials—reducing cycle times, elevating protocol adherence, and accelerating patient access to innovative treatments.